A Study of EMB-09 in Participants With Advanced or Metastatic Solid Tumors.

Clinical trial NCT05263180 · UNKNOWN

Trial details

NCT number: NCT05263180
Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2022-07-25
Primary completion: 2023-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.